ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

“Soft Soap” Comprehensive Center Review Still Stung Some; NSAB Left With Perplexing Situations

May 26, 1978

The Duke Scandal: NEJM Retracts Potti Paper

March 4, 2011

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

In Brief: Lucius Sinks New Cancer Centers Branch Chief; Mary Sears, One Of ASCO Founders, to Retire

May 11, 1984

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987